1Department of Emergency Medicine, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea
2Department of Emergency Medicine, School of Medicine, Kyungpook National University, Daegu, Korea
© 2024 Yeungnam University College of Medicine, Yeungnam University Institute of Medical Science
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Conflicts of interest
No potential conflict of interest relevant to this article was reported.
Funding
None.
Author contributions
Conceptualization, Data curation, Formal analysis, Methodology, Project administration, Investigation: SHL, HWR; Supervision, Validation: HWR; Visualization: SHL; Writing-original draft: SHL; Writing-review & editing: HWR.
Values are presented as number only, median (interquartile range), or number (%).
COPD, chronic obstructive pulmonary disease; CPR, cardiopulmonary resuscitation; AED, automated external defibrillator; EMS, emergency medical services; TTM, targeted temperature management; ECMO, extracorporeal membrane oxygenation; ROSC, recovery of spontaneous circulation; ED, emergency department.
The adjusted variables for ED ROSC were age, sex, premorbid performance, witnesses, bystander cardiopulmonary resuscitation (CPR), bystander automated external defibrillator (AED) use, mechanical compression, shockable rhythm, epinephrine, response time, on-scene time, transport time, and number of AA attempts. The adjusted variables for survival to discharge and good neurologic outcome were age, sex, premorbid performance, witnesses, bystander CPR, bystander AED use, mechanical compression, shockable rhythm, epinephrine, response time, on-scene time, transport time, number of AA attempts, targeted temperature management supply, and extracorporeal membrane oxygenation supply.
OR, odds ratio; CI, confidence interval; ED, emergency department; ROSC, recovery of spontaneous circulation; AA, advanced airway.
The adjusted variables for ED ROSC were age, sex, performance, witnesses, bystander cardiopulmonary resuscitation (CPR), bystander automated external defibrillator (AED) use, mechanical compression, shockable rhythm, epinephrine, response time, on-scene time, transport time, and multiple airway attempts. The adjusted variables for survival to discharge and good neurologic outcome were age, sex, premorbid performance, witnesses, bystander CPR, bystander AED use, mechanical compression, epinephrine, response time, on-scene time, transport time, number of AA attempts, targeted temperature management supply, and extracorporeal membrane oxygenation supply.
OR, odds ratio; CI, confidence interval; ED, emergency department; ROSC, recovery of spontaneous circulation.
The adjusted variables for ED ROSC were age, sex, performance, witnesses, bystander cardiopulmonary resuscitation (CPR), bystander automated external defibrillator (AED) use, mechanical compression, shockable rhythm, epinephrine, response time, on-scene time, transport time, and multiple airway attempts. The adjusted variables for survival to discharge and good neurologic outcome were age, sex, performance, witnesses, bystander CPR, bystander AED use, mechanical compression, shockable rhythm, epinephrine, response time, on-scene time, transport time, multiple attempts to airway, targeted temperature management supply, and extracorporeal membrane oxygenation supply.
SGA, supraglottic airway; ETI, endotracheal intubation; OR, odds ratio; CI, confidence interval; ED, emergency department; ROSC, recovery of spontaneous circulation.
Characteristic | Total | Early AA group | Late AA group | p-value |
---|---|---|---|---|
No. of patients | 2,087 | 945 | 1,142 | |
Age (yr) | 75 (63–81) | 74 (64–81) | 75 (63–81) | 0.714 |
Male sex | 1,320 (63.2) | 598 (63.3) | 722 (63.2) | 0.507 |
Premorbid performance, good | 1,726 (82.7) | 784 (83.0) | 942 (82.5) | 0.494 |
Previous illness | ||||
Previous arrest | 10 (0.5) | 3 (0.3) | 7 (0.6) | 0.262 |
Ischemic heart disease | 211 (10.1) | 96 (10.2) | 115 (10.1) | 0.485 |
Other heart diseases | 223 (10.7) | 91 (9.6) | 132 (11.6) | 0.095 |
Cerebrovascular accident | 261 (12.5) | 123 (13.0) | 138 (12.1) | 0.266 |
Hypertension | 876 (42.0) | 399 (42.2) | 477 (41.8) | 0.391 |
Diabetes mellitus | 673 (32.2) | 302 (32.0) | 371 (32.5) | 0.450 |
COPD | 161 (7.7) | 73 (7.7) | 88 (7.7) | 0.511 |
Chronic kidney disease | 181 (8.7) | 71 (7.5) | 110 (9.6) | 0.054 |
Liver cirrhosis | 41 (2.0) | 17 (1.8) | 24 (2.1) | 0.376 |
Malignancy | 310 (14.9) | 138 (14.6) | 172 (15.1) | 0.429 |
Witness | 973 (46.6) | 413 (43.7) | 560 (49.0) | 0.009 |
Place | <0.001 | |||
Public | 298 (14.3) | 145 (15.3) | 153 (13.4) | |
Nonpublic | 1,713 (82.1) | 792 (83.8) | 921 (80.6) | |
Ambulance | 66 (3.2) | 2 (0.2) | 64 (5.6) | |
Others | 10 (0.5) | 6 (0.6) | 4 (0.4) | |
Bystander CPR | 1,163 (55.7) | 616 (65.2) | 547 (47.9) | <0.001 |
Bystander AED use | 31 (1.5) | 16 (1.7) | 15 (1.3) | 0.296 |
AA type | 0.351 | |||
Supraglottic airway | 1,563 (74.9) | 712 (75.3) | 851 (74.5) | |
Endotracheal intubation | 524 (25.1) | 233 (24.7) | 291 (25.5) | |
No. of AA attempts, ≥2 | 90 (4.3) | 23 (2.4) | 67 (5.9) | <0.001 |
EMS mechanical compression | 1,926 (92.3) | 885 (93.7) | 1,041 (91.2) | 0.020 |
Shockable rhythm | 194 (9.3) | 95 (10.1) | 99 (8.7) | 0.004 |
Intravenous epinephrine | 1,388 (66.5) | 628 (66.5) | 760 (66.5) | 0.489 |
Multiple team dispatch | 2,018 (96.7) | 932 (98.6) | 1,086 (95.1) | <0.001 |
Response time (min) | 9 (7–11) | 9 (7–11) | 9 (7–11) | 0.907 |
On-scene time (min) | 18 (15–21) | 16 (14–18) | 20 (17–23) | <0.001 |
Transport time (min) | 7 (5–10) | 6 (4–9) | 7 (5–11) | <0.001 |
TTM | 43 (2.1) | 23 (2.4) | 20 (1.8) | 0.283 |
ECMO | 30 (1.4) | 15 (1.6) | 15 (1.3) | 0.712 |
ROSC in the ED | 149 (7.1) | 63 (6.7) | 86 (7.5) | 0.249 |
Survival discharge | 29 (1.4) | 13 (1.4) | 16 (1.4) | 0.560 |
Good neurologic outcome | 14 (0.7) | 6 (0.6) | 8 (0.7) | 0.464 |
Variable | n (%) | Crude OR (95% CI) | p-value | Adjusted OR (95% CI) | p-value |
---|---|---|---|---|---|
ED ROSC | 149 (100) | ||||
Time interval to AA (min) | |||||
≤4 | 34 (22.8) | Reference | |||
5–6 | 29 (19.5) | 0.89 (0.54–1.49) | 0.664 | 0.97 (0.56–1.67) | 0.914 |
7–9 | 42 (28.2) | 1.18 (0.74–1.89) | 0.490 | 1.37 (0.82–2.29) | 0.223 |
≥10 | 44 (29.5) | 1.00 (0.63–1.59) | 0.998 | 1.32 (0.75–2.33) | 0.345 |
No. of AA attempts | 0.93 (0.40–2.16) | 0.859 | 1.11 (0.46–2.68) | 0.824 | |
Survival discharge | 29 (100) | ||||
Time interval to AA (min) | |||||
≤4 | 8 (27.6) | Reference | |||
5–6 | 5 (17.2) | 0.65 (0.21–2.01) | 0.459 | 0.79 (0.26–2.44) | 0.680 |
7–9 | 4 (13.8) | 0.47 (0.14–1.56) | 0.217 | 1.04 (0.34–3.23) | 0.944 |
≥10 | 12 (41.4) | 1.16 (0.47–2.85) | 0.754 | 1.86 (0.55–6.27) | 0.320 |
No. of AA attempts | 1.64 (0.39–7.02) | 0.502 | 2.31 (0.45–11.70) | 0.314 | |
Good neurologic outcome | 14 (100) | ||||
Time interval to AA (min) | |||||
≤4 | 4 (28.6) | Reference | |||
5–6 | 2 (14.3) | 0.53 (0.10–2.88) | 0.458 | 1.72 (0.34–8.78) | 0.512 |
7–9 | 3 (21.4) | 0.71 (0.16–3.17) | 0.650 | 0.48 (0.06–3.56) | 0.471 |
≥10 | 5 (35.7) | 0.97 (0.26–3.61) | 0.958 | 0.96 (0.91–1.01) | 0.892 |
No. of AA attempts | 3.76 (0.83–17.05) | 0.086 | 3.69 (0.45–30.63) | 0.226 |
Time interval to AA (min) | Shockable group (n=194) |
Non-shockable group (n=1,893) |
||||||||
---|---|---|---|---|---|---|---|---|---|---|
n (%) | Crude OR (95% CI) | p-value | Adjusted OR (95% CI) | p-value | n (%) | Crude OR (95% CI) | p-value | Adjusted OR (95% CI) | p-value | |
ED ROSC | 36 (100) | 113 (100) | ||||||||
≤4 | 10 (27.8) | Reference | 24 (21.2) | |||||||
5–6 | 5 (13.9) | 0.61 (0.19–1.95) | 0.406 | 0.60 (0.17–2.09) | 0.420 | 24 (21.2) | 1.03 (0.58–1.85) | 0.920 | 1.12 (0.61–2.05) | 0.725 |
7–9 | 11 (30.6) | 1.24 (0.48–3.24) | 0.659 | 2.38 (0.78–7.26) | 0.129 | 31 (25.0) | 1.21 (0.70–2.10) | 0.489 | 1.31 (0.73–2.34) | 0.360 |
≥10 | 10 (27.8) | 1.13 (0.43–3.00) | 0.809 | 3.18 (0.75–11.91) | 0.087 | 34 (27.4) | 1.06 (0.62–1.81) | 0.837 | 1.14 (0.60–2.19) | 0.683 |
Survival discharge | 13 (100) | 16 (100) | ||||||||
≤4 | 4 (30.8) | Reference | 4 (25.0) | |||||||
5–6 | 2 (15.4) | 0.64 (0.11–3.68) | 0.618 | 0.79 (0.09–6.76) | 0.831 | 3 (18.8) | 0.77 (0.17–3.45) | 0.731 | 1.20 (0.24–5.91) | 0.827 |
7–9 | 3 (23.1) | 0.80 (0.17–3.76) | 0.775 | 0.71 (0.09–5.86) | 0.750 | 1 (6.3) | 0.23 (0.23–2.07) | 0.190 | 0.34 (0.03–3.46) | 0.359 |
≥10 | 4 (30.8) | 1.11 (0.26–4.71) | 0.886 | 3.09 (0.30–32.48) | 0.347 | 8 (50.0) | 1.49 (0.45–4.97) | 0.520 | 1.35 (0.30–33.02) | 0.655 |
Good neurologic outcome | 11 (100) | 3 (100) | ||||||||
≤4 | 3 (27.3) | Reference | 1 (33.3) | |||||||
5–6 | 2 (18.2) | 0.87 (0.14–5.47) | 0.884 | 1.29 (0.14–11.78) | 0.824 | 0 (0) | 0.00 | 0.994 | 0.00 | 0.998 |
7–9 | 3 (27.3) | 1.09 (0.21–5.64) | 0.923 | 1.23 (0.14–11.19) | 0.854 | 0 (0) | 0.00 | 0.994 | 0.00 | 0.987 |
≥10 | 3 (27.3) | 1.11 (0.21–5.77) | 0.902 | 3.42 (0.27–43.11) | 0.341 | 2 (66.7) | 1.49 (0.14–16.49) | 0.745 | 0.01 (0–6.53) | 0.704 |
Time interval to AA (min) | SGA group (n=1,563) |
ETI group (n=524) |
||||||||
---|---|---|---|---|---|---|---|---|---|---|
n (%) | Crude OR (95% CI) | p-value | Adjusted OR (95% CI) | p-value | n (%) | Crude OR (95% CI) | p-value | Adjusted OR (95% CI) | p-value | |
ED ROSC | 115 (100) | 34 (100) | ||||||||
≤4 | 28 (24.3) | Reference | 6 (17.6) | |||||||
5–6 | 23 (20.0) | 0.91 (0.52–1.62) | 0.756 | 0.96 (0.52–1.77) | 0.891 | 6 (17.6) | 0.87 (0.27–2.79) | 0.819 | 1.04 (0.30–3.54) | 0.954 |
7–9 | 31 (27.0) | 1.13 (0.66–1.92) | 0.653 | 1.25 (0.70–2.22) | 0.455 | 11 (32.4) | 1.44 (0.52–4.03) | 0.486 | 2.06 (0.61–8.04) | 0.210 |
≥10 | 33 (28.7) | 0.92 (0.55–1.55) | 0.753 | 1.11 (0.58–2.12) | 0.756 | 11 (32.4) | 1.37 (0.49–3.82) | 0.549 | 2.21 (0.61–8.04) | 0.227 |
Survival discharge | 26 (100) | 3 (100) | ||||||||
≤4 | 7 (26.9) | Reference | 1 (33.3) | |||||||
5–6 | 4 (15.4) | 0.64 (0.18–2.19) | 0.473 | 0.82 (0.21–3.18) | 0.773 | 1 (33.3) | 0.87 (0.05–14.08) | 0.922 | 0.00 | 0.999 |
7–9 | 4 (15.4) | 0.57 (0.17–1.97) | 0.378 | 0.48 (0.12–1.90) | 0.297 | 0 (0) | 0.00 | 0.996 | 0.00 | 0.996 |
≥10 | 11 (42.3) | 1.23 (0.47–3.21) | 0.668 | 1.90 (0.53–6.80) | 0.323 | 1 (33.3) | 0.72 (0.05–11.69) | 0.819 | 0.00 | 0.998 |
Good neurologic outcome | 12 (100) | 2 (100) | ||||||||
≤4 | 3 (25.0) | Reference | 1 (50.0) | |||||||
5–6 | 1 (8.3) | 0.37 (0.04–3.59) | 0.392 | 0.33 (0.02–4.47) | 0.403 | 1 (50.0) | 0.88 (0.05–14.21) | 0.927 | 0.00 | 0.992 |
7–9 | 3 (25.0) | 1.01 (0.20–5.04) | 0.990 | 0.54 (0.07–4.30) | 0.558 | 0 (0) | 0.00 | 0.996 | 0.00 | 0.994 |
≥10 | 5 (41.7) | 1.31 (0.31–5.52) | 0.712 | 0.77 (0.09–6.52) | 0.814 | 0 (0) | 0.00 | 0.996 | 0.00 | 0.997 |
Values are presented as number only, median (interquartile range), or number (%). COPD, chronic obstructive pulmonary disease; CPR, cardiopulmonary resuscitation; AED, automated external defibrillator; EMS, emergency medical services; TTM, targeted temperature management; ECMO, extracorporeal membrane oxygenation; ROSC, recovery of spontaneous circulation; ED, emergency department.
The adjusted variables for ED ROSC were age, sex, premorbid performance, witnesses, bystander cardiopulmonary resuscitation (CPR), bystander automated external defibrillator (AED) use, mechanical compression, shockable rhythm, epinephrine, response time, on-scene time, transport time, and number of AA attempts. The adjusted variables for survival to discharge and good neurologic outcome were age, sex, premorbid performance, witnesses, bystander CPR, bystander AED use, mechanical compression, shockable rhythm, epinephrine, response time, on-scene time, transport time, number of AA attempts, targeted temperature management supply, and extracorporeal membrane oxygenation supply. OR, odds ratio; CI, confidence interval; ED, emergency department; ROSC, recovery of spontaneous circulation; AA, advanced airway.
The adjusted variables for ED ROSC were age, sex, performance, witnesses, bystander cardiopulmonary resuscitation (CPR), bystander automated external defibrillator (AED) use, mechanical compression, shockable rhythm, epinephrine, response time, on-scene time, transport time, and multiple airway attempts. The adjusted variables for survival to discharge and good neurologic outcome were age, sex, premorbid performance, witnesses, bystander CPR, bystander AED use, mechanical compression, epinephrine, response time, on-scene time, transport time, number of AA attempts, targeted temperature management supply, and extracorporeal membrane oxygenation supply. OR, odds ratio; CI, confidence interval; ED, emergency department; ROSC, recovery of spontaneous circulation.
The adjusted variables for ED ROSC were age, sex, performance, witnesses, bystander cardiopulmonary resuscitation (CPR), bystander automated external defibrillator (AED) use, mechanical compression, shockable rhythm, epinephrine, response time, on-scene time, transport time, and multiple airway attempts. The adjusted variables for survival to discharge and good neurologic outcome were age, sex, performance, witnesses, bystander CPR, bystander AED use, mechanical compression, shockable rhythm, epinephrine, response time, on-scene time, transport time, multiple attempts to airway, targeted temperature management supply, and extracorporeal membrane oxygenation supply. SGA, supraglottic airway; ETI, endotracheal intubation; OR, odds ratio; CI, confidence interval; ED, emergency department; ROSC, recovery of spontaneous circulation.